CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings

Discriminating Lyme Neuroborreliosis from Other Neuroinflammatory Diseases by Levels of CXCL13 in Cerebrospinal Fluid

(2011) N. D. van Burgel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

CXCL13 is a potential biomarker for Lyme neuroborreliosis

(2011) Katie Kingwell   Nature Reviews Neurology

A prospective study on the role of CXCL13 in Lyme neuroborreliosis

(2011) C. Schmidt et al.   NEUROLOGY

Outer Surface Protein C Is a Dissemination-Facilitating Factor of Borrelia burgdorferi during Mammalian Infection

(2011) Sunita V. Seemanapalli et al.   PLoS One

Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis

(2010) Ivar Tjernberg et al.   JOURNAL OF INFECTION

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

(2009) Å. Mygland et al.   EUROPEAN JOURNAL OF NEUROLOGY

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis

(2009) Tobias A Rupprecht et al.   Journal of Neuroinflammation

The chemokine CXCL13 in acute neuroborreliosis

(2009) M. Senel et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY